Structural studies on bioactive compounds.: 40.: Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzothiazoles

被引:84
作者
Vasselin, David A.
Westwell, Andrew D.
Matthews, Charles S.
Bradshaw, Tracey D.
Stevens, Malcolm F. G. [1 ]
机构
[1] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Canc Res UK Expt Canc Chemotherapy Res Grp, Nottingham NG7 2RD, England
[2] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
关键词
D O I
10.1021/jm060359j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of fluoro-, methoxyl-, and amino-substituted isoflavones have been synthesized as potential antitumor agents based on structural similarities to known flavones and isoflavones ( quercetin and genistein respectively) and antitumor 2-phenylbenzothiazoles. Target compounds were synthesized using palladium-catalyzed coupling methodologies to construct the central aryl carbon-carbon single bond. The new isoflavone derivatives were tested for in vitro activity in human breast ( MDA-MB-468 and MCF-7) and colon ( HT29 and HCT-116) cancer cell lines. Low micromolar GI(50) values were obtained in a number of cases, with the MDA-MB-468 cell line being the most sensitive overall. Notably, significant potentiation of growth inhibitory activity ( GI(50) < 1 AM for 12d, 12f, 12h, 12k, 12l, 12o but not the methylene-bridged derivative 12i) was observed when MDA-MB-468 cells were co-incubated with TBDD, a powerful inducer of cytochrome P450 ( CYP)-1A1 activity, suggesting that isoflavone derivatives can act as substrates for CYP1A1 bioactivation.
引用
收藏
页码:3973 / 3981
页数:9
相关论文
共 35 条
[1]   Structure-activity relationships of the 7-substituents of 5,4′-diamino-6,8,3:-trifluoroflavone, a potent antitumor agent [J].
Akama, T ;
Ishida, H ;
Kimura, U ;
Gomi, K ;
Saito, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (12) :2056-2067
[2]   Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[3]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate [J].
Bradshaw, TD ;
Westwell, AD .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (08) :1009-1021
[6]  
Chua MS, 2000, CANCER RES, V60, P5196
[7]   Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: An SAR study [J].
Daskiewicz, JB ;
Depeint, F ;
Viornery, L ;
Bayet, C ;
Comte-Sarrazin, G ;
Comte, G ;
Gee, JM ;
Johnson, IT ;
Ndjoko, K ;
Hostettmann, K ;
Barron, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) :2790-2804
[8]  
Evans PA, 1997, SYNLETT, P968
[9]   The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models [J].
Fichtner, I ;
Monks, A ;
Hose, C ;
Stevens, MFG ;
Bradshaw, TD .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 87 (01) :97-107
[10]   Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7 [J].
Fretland, AJ ;
Safe, S ;
Hankinson, O .
CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (02) :161-170